On December 2, during a meeting at the Silesian Center for Entrepreneurship, Acellmed received a distinction as a LEADER OF CHANGE in the medical category. Five companies were awarded, including ACM as the only company in this category.
…
We are pleased to announce that on 08/11/2022 a Scientific Cooperation Agreement was signed between the M. Skłodowska-Curie National Research Institute of Oncology Gliwice Branch and the consortium: Acellmed Sp. z o.o. and Silesian Park of Medical Technology Kardio-Med Silesia. The scientific cooperation will consist in verifying the therapeutic activity and specificity of action of the anti-acute myeloid leukemia (AML) drug being developed by the Acellmed – ŚPTM Kardio-Med Silesia consortium on leukemic cells of AML patients being treated at the M. Skłodowska-Curie National Research Institute of Oncology Gliwice Branch.
…
Nearly 150 applications were submitted to the prestigious Start-up Challenge 2022 competition, organized within the framework of 14th European Economic Congress. As a result, the most interesting start-ups, divided into five contest categories, were selected. The best 15, who qualified for the semi-finals, presented their work to a broad audience during the European Economic Congress,…
